
Overview
Background
A/Prof Sumaira Hasnain graduated with her PhD in December 2010 from The University of Manchester and is an Associate Professor at Mater Research with a team of eight researchers. A/Prof Hasnain was the first globally to demonstrate that immunity can modulate protein production in secretory cells in infection and chronic diseases. Her long-term vision has been to characterise these novel immune factors and manipulate them therapeutically using pre-clinical models of immune-driven pathologies.
A/Prof Hasnain holds a patent for targeted immunotherapy in metabolic disease which has led to the formation of a spin-off company, Jetra Therapeutics and venture capitalist funding. She has a rapid upward trajectory in research, evident by extensive body of high-quality publications including in Nature Medicine, Nature Communications, Journal of Experimental Medicine, Oncogene and Gastroenterology. She has been awarded more than $9 million in competitive funding and recently gained the National Health and Medical Research Council L1 Investigator Grant. A/Prof Hasnain has won 21 awards to date, including the Commercialisation award from The University of Queensland in 2022 and the Gastroenterological Society for Australasia; Lawrie Powell Award in 2023.
Availability
- Dr Sumaira Hasnain is:
- Available for supervision
- Media expert
Fields of research
Qualifications
- Doctor of Philosophy, The University of Manchester
Research interests
-
Understanding Immune Regulation of Cellular Stress
Using different disease models to target cellular stress and alleviate pathology
Research impacts
We have recently described for the first time that cytokines have the ability to stop or promote protein biosynthesis via the regulation of endoplasmic reticulum (ER) stress and oxidative stress. We are targetting the immune system to repair abnormal cellular protein secretion in conditions such as diabetes, which affects 1 in 20 Australians and inflammatory bowel disease, which affects 1 in 250 Australians. This research also has implications for other diseases and infections that have a high burden on the healthcare system. The ultimate aim of this research is to devise new strategies for treatments to aid recovery following infections and to alleviate chronic inflammatory disease.
Works
Search Professor Sumaira Hasnain’s works on UQ eSpace
2021
Journal Article
DP1 prostanoid receptor activation increases the severity of an acute lower respiratory viral infection in mice via TNF-α-induced immunopathology
Ullah, Md Ashik, Rittchen, Sonja, Li, Jia, Hasnain, Sumaira Z. and Phipps, Simon (2021). DP1 prostanoid receptor activation increases the severity of an acute lower respiratory viral infection in mice via TNF-α-induced immunopathology. Mucosal Immunology, 14 (4), 963-972. doi: 10.1038/s41385-021-00405-7
2021
Journal Article
A nucleotide analog prevents colitis associated cancer via Β-catenin independently of inflammation and autophagy
Sheng, Yong Hua, Giri, Rabina, Davies, Julie, Schreiber, Veronika, Alabbas, Saleh, Movva, Ramya, He, Yaowu, Wu, Andy, Hooper, John, McWhinney, Brett, Oancea, Iulia, Kijanka, Gregor, Hasnain, Sumaira, Lucke, Andrew J., Fairlie, David P., McGuckin, Michael A., Florin, Timothy H. and Begun, Jakob (2021). A nucleotide analog prevents colitis associated cancer via Β-catenin independently of inflammation and autophagy. Cellular and Molecular Gastroenterology and Hepatology, 11 (1), 33-53. doi: 10.1016/j.jcmgh.2020.05.012
2021
Journal Article
Gut microbiota shape the inflammatory response in mice with an epithelial defect
Wang, Ran, Moniruzzaman, Md, Wong, Kuan Yau, Wiid, Percival, Harding, Alexa, Giri, Rabina, Tong, Wendy Hui, Creagh, Jackie, Begun, Jakob, McGuckin, Michael A. and Hasnain, Sumaira Z. (2021). Gut microbiota shape the inflammatory response in mice with an epithelial defect. Gut microbes, 13 (1), 1-18. doi: 10.1080/19490976.2021.1887720
2020
Journal Article
One‐pot synthesis of pH‐responsive eudragit‐mesoporous silica nanocomposites enable colonic delivery of glucocorticoids for the treatment of inflammatory bowel disease
Qu, Zhi, Wong, Kuan Yau, Moniruzzaman, Md., Begun, Jakob, Santos, Hélder A, Hasnain, Sumaira Z., Kumeria, Tushar, McGuckin, Michael A. and Popat, Amirali (2020). One‐pot synthesis of pH‐responsive eudragit‐mesoporous silica nanocomposites enable colonic delivery of glucocorticoids for the treatment of inflammatory bowel disease. Advanced Therapeutics, 4 (2) 2000165, 2000165. doi: 10.1002/adtp.202000165
2020
Journal Article
Influence of the MUC1 cell surface mucin on gastric mucosal gene expression profiles in response to Helicobacter pylori infection in mice
Sheng, Yong H., Ng, Garrett Z., Summers, Kim M., Every, Alison L., Price, Gareth, Hasnain, Sumaira Z., Sutton, Philip and McGuckin, Michael A. (2020). Influence of the MUC1 cell surface mucin on gastric mucosal gene expression profiles in response to Helicobacter pylori infection in mice. Frontiers in Cellular and Infection Microbiology, 10 343, 343. doi: 10.3389/fcimb.2020.00343
2020
Journal Article
High glucose levels increase influenza-associated damage to the pulmonary epithelial-endothelial barrier
Hulme, Katina Dee, Yan, Limin, Marshall, Rebecca J., Bloxham, Conor J., Upton, Kyle R., Hasnain, Sumaira Z., Bielefeldt-Ohmann, Helle, Loh, Zhixuan, Ronacher, Katharina, Chew, Keng Yih , Gallo, Linda A. and Short, Kirsty Renfree (2020). High glucose levels increase influenza-associated damage to the pulmonary epithelial-endothelial barrier. eLife, 9 e56907, 1-20. doi: 10.7554/elife.56907
2020
Journal Article
Effect of Different Volumes of Interval Training and Continuous Exercise on Interleukin-22 in Adults with Metabolic Syndrome: A Randomized Trial
Ramos, Joyce S., Dalleck, Lance C., Stennett, Rebecca C., Mielke, Gregore I., Keating, Shelley E., Murray, Lydia S., Hasnain, Sumaira Z., Fassett, Robert G., McGuckin, Michael, Croci, Ilaria and Coombes, Jeff S. (2020). Effect of Different Volumes of Interval Training and Continuous Exercise on Interleukin-22 in Adults with Metabolic Syndrome: A Randomized Trial. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, 13, 2443-2453. doi: 10.2147/dmso.s251567
2020
Journal Article
Airway mucus hyperconcentration in non–cystic fibrosis bronchiectasis
Ramsey, Kathryn A., Chen, Alice C. H., Radicioni, Giorgia, Lourie, Rohan, Martin, Megan, Broomfield, Amy, Sheng, Yong H., Hasnain, Sumaira Z., Radford-Smith, Graham, Simms, Lisa A., Burr, Lucy, Thornton, David J., Bowler, Simon D., Livengood, Stephanie, Ceppe, Agathe, Knowles, Michael R., Noone, Peadar G., Donaldson, Scott H., Hill, David B., Ehre, Camille, Button, Brian, Alexis, Neil E., Kesimer, Mehmet, Boucher, Richard C. and McGuckin, Michael A. (2020). Airway mucus hyperconcentration in non–cystic fibrosis bronchiectasis. American Journal of Respiratory and Critical Care Medicine, 201 (6), 661-670. doi: 10.1164/rccm.201906-1219OC
2020
Conference Publication
Harnessing the therapeutic potential of interleukin-22 in neonatal respiratory viral infection
Hasnain, S., Wang, R., Taylor, S., Wong, K. Y., Moniruzzaman, M., Upham, J., Spann, K., Mcguckin, M. A., Burr, L. and Phipps, S. (2020). Harnessing the therapeutic potential of interleukin-22 in neonatal respiratory viral infection. TSANZSRS 2020 The Australia & New Zealand Society of Respiratory Science and The Thoracic Society of Australia and New Zealand (ANZSRS/TSANZ) Annual Scientific Meeting for Leaders in Lung Health & Respiratory Science, Melbourne, VIC, Australia, 27–31 March 2020. Richmond, VIC, Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/resp.13777
2020
Conference Publication
Blocking endogenous IL-22 is associated with reduced viral load and improved lung pathology in respiratory viral infections
Wang, R., Moniruzzaman, M., Wang, K., Upham, J. W., McGuckin, M., Phipps, S. and Hasnain, S. Z. (2020). Blocking endogenous IL-22 is associated with reduced viral load and improved lung pathology in respiratory viral infections. International Conference of the American-Thoracic-Society (ATS), Online, 10 November 2020. New York, NY, United States: American Thoracic Society. doi: 10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a6530
2019
Journal Article
A cost-effective three-dimensional culture platform functionally mimics the adipose tissue microenvironment surrounding the kidney
Shen, Kunyu, Vesey, David A., Hasnain, Sumaira Z., Zhao, Kong-Nan, Wang, Haolu, Johnson, David W., Saunders, Nicholas, Burgess, Melinda and Gobe, Glenda C. (2019). A cost-effective three-dimensional culture platform functionally mimics the adipose tissue microenvironment surrounding the kidney. Biochemical and Biophysical Research Communications, 522 (3), 736-742. doi: 10.1016/j.bbrc.2019.11.119
2019
Journal Article
Rationally designed dendritic silica nanoparticles for oral delivery of exenatide
Abeer, Muhammad Mustafa, Meka, Anand Kumar, Pujara, Naisarg, Kumeria, Tushar, Strounina, Ekaterina, Nunes, Rute, Costa, Ana, Sarmento, Bruno, Hasnain, Sumaira Z., Ross, Benjamin P. and Popat, Amirali (2019). Rationally designed dendritic silica nanoparticles for oral delivery of exenatide. Pharmaceutics, 11 (8) 418, 418. doi: 10.3390/pharmaceutics11080418
2019
Journal Article
MUC13 promotes the development of colitis-associated colorectal tumors via β-catenin activity
Sheng, Yong Hua, Wong, Kuan Yau, Seim, Inge, Wang, Ran, He, Yaowu, Wu, Andy, Patrick, Maya, Lourie, Rohan, Schreiber, Veronika, Giri, Rabina, Ng, Choa Ping, Popat, Amirali, Hooper, John, Kijanka, Gregor, Florin, Timothy H., Begun, Jakob, Radford, Kristen J., Hasnain, Sumaira and McGuckin, Michael A. (2019). MUC13 promotes the development of colitis-associated colorectal tumors via β-catenin activity. Oncogene, 38 (48), 7294-7310. doi: 10.1038/s41388-019-0951-y
2019
Journal Article
Interleukin (IL)-22 from IL-20 Subfamily of cytokines induces colonic epithelial cell proliferation predominantly through ERK1/2 pathway
Moniruzzaman, Md., Wang, Ran, Jeet, Varinder, McGuckin, Michael A. and Hasnain, Sumaira Z. (2019). Interleukin (IL)-22 from IL-20 Subfamily of cytokines induces colonic epithelial cell proliferation predominantly through ERK1/2 pathway. International Journal of Molecular Sciences, 20 (14) 3468, 3468. doi: 10.3390/ijms20143468
2019
Journal Article
Fibre intake is independently associated with increased circulating interleukin-22 in individuals with metabolic syndrome
Torquati, Luciana, Coombes, Jeff S., Murray, Lydia, Hasnain, Sumaira Z., Mallard, Alistair R., McGuckin, Michael A., Fassett, Robert G., Croci, Ilaria and Ramos, Joyce S. (2019). Fibre intake is independently associated with increased circulating interleukin-22 in individuals with metabolic syndrome. Nutrients, 11 (4) 815, 815. doi: 10.3390/nu11040815
2019
Journal Article
Interleukin-22: friend or foe?
Hasnain, Sumaira Z. and Begun, Jakob (2019). Interleukin-22: friend or foe?. Immunology and Cell Biology, 97 (4), 355-357. doi: 10.1111/imcb.12249
2019
Conference Publication
Interleukin-20 subfamily cytokines in controlling intestinal inflammation and epithelial barrier integrity
Moniruzzaman, M., Wang, R., Wong, K., Tong, H., McGuckin, M. and Hasnain, S. (2019). Interleukin-20 subfamily cytokines in controlling intestinal inflammation and epithelial barrier integrity. Congress of ECCO, Copenhagen, Denmark, 6-9 March 2019. Oxford, United Kingdom: Oxford University Press. doi: 10.1093/ecco-jcc/jjy222.044
2018
Conference Publication
Interleukin-22: A potential therapy to control intestinal inflammation
Moniruzzaman, M., Wang, R., Wong, K. Y., Tong, H., McGuckin, M. A. and Hasnain, S. Z. (2018). Interleukin-22: A potential therapy to control intestinal inflammation. Gastroenterological Society of Australia (GESA) Australian Gastroenterology Week (AGW) “Gut Matters”, Brisbane, QLD, Australia, 8-10 September 2018. Richmond, VIC, Australia: John Wiley & Sons.
2018
Conference Publication
Enteric microbiota shape the inflammatory response in mice with a Muc2 misfolding mutation
Wang, R., Giri, R., Moniruzzaman, M., Tong, H., Wong, K. Y., Begun, J., McGuckin, M. A. and Hasnain, S. Z. (2018). Enteric microbiota shape the inflammatory response in mice with a Muc2 misfolding mutation. Gastroenterological Society of Australia (GESA) Australian Gastroenterology Week (AGW) “Gut Matters”, Brisbane, QLD, Australia, 8-10 September 2018. Richmond, VIC, Australia: John Wiley & Sons.
2018
Journal Article
PPARγ is reduced in the airways of non-CF bronchiectasis subjects and is inversely correlated with the presence of Pseudomonas aeruginosa
Burr, Lucy D., Rogers, Geraint B., Chen, Alice C.-H., Taylor, Steven L., Bowler, Simon D., Keating, Rebecca L., Martin, Megan L., Hasnain, Sumaira Z. and McGuckin, Michael A. (2018). PPARγ is reduced in the airways of non-CF bronchiectasis subjects and is inversely correlated with the presence of Pseudomonas aeruginosa. PLoS ONE, 13 (8) e0202296, e0202296. doi: 10.1371/journal.pone.0202296
Funding
Current funding
Supervision
Availability
- Dr Sumaira Hasnain is:
- Available for supervision
Before you email them, read our advice on how to contact a supervisor.
Available projects
-
Disrupting Immune Responses to Reverse Fibrosis
Biomedical and clinical sciences
Project description
Intestinal fibrosis is a debilitating complication affecting a significant portion of patients with Inflammatory Bowel Disease (IBD), including Ulcerative Colitis (UC) and Crohn's Disease (CD). Chronic inflammation within the intestinal tract leads to excessive collagen production by fibroblasts, resulting in luminal narrowing, obstruction, and a significant decline in quality of life.
Recent studies have suggested a potential role for interleukin-24 (IL-24) in the pathogenesis of IBD. IL-24 is a cytokine with both pro-inflammatory and anti-inflammatory properties, and it has been implicated in various fibrotic diseases.
This research aims to investigate the specific role of IL-24 in driving intestinal fibrosis in IBD, with a particular focus on its ability to activate transforming growth factor-beta (TGF-beta), a key mediator of fibrosis.
Specific Research Questions:
- Expression of IL-24 and TGF-beta in fibrotic intestinal tissue: Are IL-24 and TGF-beta upregulated in fibrotic regions of the intestine in IBD patients?
- IL-24-mediated activation of TGF-beta: Does IL-24 directly or indirectly stimulate the production and activation of TGF-beta in intestinal fibroblasts?
- Role of TGF-beta in IL-24-induced fibrosis: What are the downstream effects of TGF-beta activation in promoting intestinal fibrosis?
- Therapeutic potential of targeting IL-24 or TGF-beta: Can inhibiting IL-24 or TGF-beta pathways be a potential therapeutic strategy for preventing or treating intestinal fibrosis in IBD?
-
The Link Between Cellular Stress and Antigen Presentation
The endoplasmic reticulum (ER) plays a crucial role in the production and presentation of MHC Class II antigens, which are essential for the immune system to recognize and eliminate foreign invaders. When proteins are misfolded or improperly assembled in the ER, it can trigger a cellular stress response known as ER stress. This stress can impact the generation and presentation of MHC Class II antigens in several ways. Our focus has been on antigen presentation by nonprofessional antigen presenting cells like epithelial cells. Project Aim: To investigate the complex relationship between protein misfolding, ER stress, and MHC Class II antigen presentation, with a focus on understanding how these factors influence the development of immune responses, particularly those involving CD4+ T cells. Expected outcomes and deliverables: This project will be undertaken at UQ (Mater Research Institute) within the Translational Research Institute (TRI) which is a collaborative building that incorporates over 1200 research scientists and students. TRI also provides an exceptional research environment with access to state-of-art facilities including flow cytometry, microscopy and a strong network of research support professionals. There is support for PhD students, through UQ as well as Mater Student Committee (sMater). The honours student will learn a range of techniques, in particular, flow cytometry, histology, Confocal Microscopy and preclinical animal work. There is a potential of extending the honours project into a PhD project.
-
Decoding the IL-22RA1-Insulin Biosynthesis Link: A New Target for Diabetes
The IL-22RA1 receptor is abundant in the pancreas, and external IL-22 has been shown to improve pancreatic islet health and insulin secretion. However, the natural function of IL-22RA1 signalling within these cells is incompletely understood. Our recent work has shown that endogenous IL-22RA1 signalling in regulating insulin secretion, islet regeneration, and overall metabolic health. Understanding the specific mechanisms involved in IL-22RA1-mediated regulation of pancreatic beta cell function could lead to novel therapeutic strategies for diabetes and other metabolic disorders. This project will focus on investigating the exact mechanisms by which IL-22 regulates these processes, with a particular focus on calcium storage and cytoskeletal changes. Expected outcomes and deliverables: This project will be undertaken at UQ (Mater Research Institute) within the Translational Research Institute (TRI) which is a collaborative building that incorporates over 1200 research scientists and students. TRI also provides an exceptional research environment with access to state-of-art facilities including flow cytometry, microscopy and a strong network of research support professionals. There is support for PhD students, through UQ as well as Mater Student Committee (sMater). The honours student will learn a range of techniques, in particular, flow cytometry, histology, Confocal Microscopy and preclinical animal work. There is a potential of extending the honours project into a PhD project.
Supervision history
Current supervision
-
Doctor Philosophy
Decline of Unfolded Protein Response with Age Increases Susceptibility to Infection and Inflammation
Principal Advisor
Other advisors: Associate Professor Lucy Burr
-
Doctor Philosophy
Achieving Remission in Asthma
Associate Advisor
Other advisors: Associate Professor Lucy Burr
Completed supervision
-
2024
Doctor Philosophy
Examining the Role of Endogenous and Exogenous Interleukin-22 Signaling in Metabolic Dysfunction-Associated Steatotic Liver Disease
Principal Advisor
Other advisors: Associate Professor Graeme Macdonald
-
2022
Master Philosophy
Targeting Intestinal Epithelial Cell-Derived Interleukin-23 (p19) To Improve Intestinal Barrier Integrity in Inflammatory Bowel Disease
Principal Advisor
Other advisors: Dr Ran Wang, Associate Professor Jakob Begun
-
2020
Doctor Philosophy
THERAPEUTIC MANIPULATION OF INTERLEUKIN-20 SUBFAMILY OF CYTOKINES IN ULCERATIVE COLITIS
Principal Advisor
Other advisors: Dr Ran Wang
-
2024
Doctor Philosophy
Smart Silica nanoparticles for oral biologics delivery
Associate Advisor
Other advisors: Professor Amirali Popat
-
2020
Doctor Philosophy
The role of the adipose tissue microenvironment in kidney cancer
Associate Advisor
Other advisors: Professor David Johnson, Associate Professor David Vesey
-
2020
Doctor Philosophy
Local Delivery of Anti-inflammatory drugs with Functionalized Silica Nanoparticles for Inflammatory Bowel Disease
Associate Advisor
Other advisors: Professor Amirali Popat
-
2019
Doctor Philosophy
Targeted Delivery of Peptides and Proteins Using Functionalised Silica Nanoparticles
Associate Advisor
Other advisors: Dr Ben Ross, Professor Amirali Popat
-
2015
Doctor Philosophy
Targeting IL-23/TH17 Axis in Suppressing Intestinal Inflammation
Associate Advisor
Media
Enquiries
Contact Dr Sumaira Hasnain directly for media enquiries about:
- Cellular Stress
- Immune System
- Infectious Diseases
Need help?
For help with finding experts, story ideas and media enquiries, contact our Media team: